BALCHEM CORP filed this 8-K on February 20, 2026
BALCHEM CORP - 8-K - 20260220 - CASH_FLOW
(unaudited)
Year Ended December 31,
20252024
Cash flows from operating activities:
   Net earnings $154,845 $128,475 
Adjustments to reconcile net earnings to net cash provided by operating activities:
        Depreciation and amortization45,690 47,973 
        Stock compensation expense 18,057 16,675 
        Other adjustments 5,427 (5,007)
        Changes in assets and liabilities, net of acquired balances(7,463)(6,117)
  Net cash provided by operating activities216,556 181,999 
 
Cash flows from investing activities:
   Capital expenditures and intangible assets acquired(43,489)(35,661)
   Cash paid for acquisitions, net of cash acquired(323)(24,164)
   Proceeds from sale of assets274 359 
   Investment in affiliates(353)(270)
  Net cash used in investing activities(43,891)(59,736)
Cash flows from financing activities:
   Proceeds from revolving loan88,000 26,000 
   Principal payments on revolving debt(114,000)(145,569)
 Principal payments on finance lease(194)(216)
   Proceeds from stock options exercised9,307 17,228 
   Dividends paid(28,287)(25,576)
   Repurchases of common stock(107,636)(5,682)
  Net cash used in financing activities(152,810)(133,815)
   Effect of exchange rate changes on cash5,200 (3,380)
Increase (decrease) in cash and cash equivalents25,055 (14,932)
Cash and cash equivalents, beginning of period49,515 64,447 
Cash and cash equivalents, end of period$74,570 $49,515